Results for “Dr. Rudolph Tanzi”

Who you are, how you perceive yourself, and how others perceive you, all are enmeshed within this tapestry, which consists of billions of neuronal connections. Alzheimer's, in essence, pulls this tapestry apart, thread by thread.

Alzheimer's disease researcher and Harvard Medical School neuroscientist

If we consider the United States, where potentially 40 million people could discover through brain imaging or blood tests that they have amyloid in their brains, the question arises: how can healthcare systems afford to provide a $100,000 per year therapy to so many people? It's simply not feasible.

Alzheimer's disease researcher and Harvard Medical School neuroscientist

In the future, these kinds of blood tests will become commonplace. They will allow us to offer treatments for Alzheimer's disease 10, 20, or even 30 years before symptoms start to manifest, much like how we currently handle cholesterol. This early detection and intervention will be our strategy for combating Alzheimer's.

Alzheimer's disease researcher and Harvard Medical School neuroscientist

Surveys show that, surprisingly, more people fear Alzheimer's disease more than they do cancer. This is due to the fact that Alzheimer's isn't a quick affliction; it extends over a period of 8-20 years, during which individuals slowly lose themselves. This disease methodically dismantles your neural network, a network that represents a tapestry of experiences and connections you've built throughout your life.

Alzheimer's disease researcher and Harvard Medical School neuroscientist

Our brains consist of about 100 billion nerve cells and neurons, with a potential for making anywhere from tens to hundreds of trillions, some even say a quadrillion, connections known as synapses. Due to a phenomenon known as neuroplasticity, our neural network continually restructures itself. Each time we learn something new or encounter a fresh experience, we trigger a reconfiguration of our brains.

Alzheimer's disease researcher and Harvard Medical School neuroscientist

Alzheimer's starts its destructive process 30 years prior to its typical diagnosis. Therefore, when considering the prevalence of this disease, we're speaking of 7 million diagnosed patients in the US. But then, one might ask, how many Americans currently have the initial stages of Alzheimer's, characterized by amyloid plaques, cell death, tangles, and inflammation, already festering in their brains? I concur with the higher estimates, suggesting around 40 million people.

Alzheimer's disease researcher and Harvard Medical School neuroscientist

In the future, these blood tests will allow us to offer treatments for Alzheimer's disease 10, 20, or even 30 years before symptoms start to manifest, much like how we currently handle cholesterol. This early detection and intervention will be our strategy for combating Alzheimer's.

Alzheimer's disease researcher and Harvard Medical School neuroscientist

When considering the prevalence of this disease, we're speaking of 7 million diagnosed patients in the US. But how many Americans currently have the initial stages of Alzheimer's already festering in their brains? I concur with the higher estimates, suggesting around 40 million people.

Alzheimer's disease researcher and Harvard Medical School neuroscientist

Alzheimer's starts its destructive process 30 years prior to its typical diagnosis. If we were to compare this to our approach with heart disease, it's like only making a diagnosis when a coronary bypass is needed.

Alzheimer's disease researcher and Harvard Medical School neuroscientist

Each time we learn something new or encounter a fresh experience, we trigger a reconfiguration of our brains. Neuroplasticity is highest during youth, explaining why children and young adults up to the age of 25 absorb knowledge so rapidly. Their learning capacity is immense, akin to sponges soaking up water.

Alzheimer's disease researcher and Harvard Medical School neuroscientist